company-logo

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

INVO Bioscience Dividend Announcement

INVO Bioscience does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on INVO Bioscience dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

INVO Bioscience Dividend History

INVO Bioscience Dividend Yield

INVO Bioscience current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing INVO Bioscience stock? Use our calculator to estimate your expected dividend yield:

INVO Bioscience Financial Ratios

P/E ratio-0.42
PEG ratio0.10
P/B ratio2.21
ROE-1073.76%
Payout ratio0.00%
Current ratio0.30
Quick ratio0.27
Cash Ratio0.12

INVO Bioscience Dividend FAQ

Does INVO Bioscience stock pay dividends?
INVO Bioscience does not currently pay dividends to its shareholders.
Has INVO Bioscience ever paid a dividend?
No, INVO Bioscience has no a history of paying dividends to its shareholders. INVO Bioscience is not known for its dividend payments.
Why doesn't INVO Bioscience pay dividends?
There are several potential reasons why INVO Bioscience would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will INVO Bioscience ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While INVO Bioscience has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is INVO Bioscience a dividend aristocrat?
INVO Bioscience is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is INVO Bioscience a dividend king?
INVO Bioscience is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is INVO Bioscience a dividend stock?
No, INVO Bioscience is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy INVO Bioscience stocks?
To buy INVO Bioscience you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy INVO Bioscience stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.